His Cancer Meds Were Nearly $1K A Pill. How Did That Happen?
Fresh Air
00:00
Manipulating Drug Prices: The Revlimid Case and Its Implications
This chapter examines the unethical price manipulation of the cancer drug Revlimid, as revealed by whistleblower complaints and internal company pressures. It also explores the broader implications of high American drug prices and the systemic issues within the healthcare payment structure.
Transcript
Play full episode
